Boiron SA
PAR:BOI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Boiron SA
PAR:BOI
|
FR |
|
B
|
BioForce Nanosciences Holdings Inc
OTC:BFNH
|
US |
|
Dentsu Group Inc
TSE:4324
|
JP |
|
Coconala Inc
TSE:4176
|
JP |
|
K Wah International Holdings Ltd
HKEX:173
|
HK |
|
L
|
Luzerner Kantonalbank AG
SIX:LUKN
|
CH |
|
T
|
Tanaka Co Ltd
F:TDJ
|
JP |
|
E
|
Endesa SA
DUS:ENA
|
ES |
|
S
|
secunet Security Networks AG
DUS:YSN
|
DE |
|
Precinct Properties New Zealand Ltd
NZX:PCT
|
NZ |
|
Genesis AI Corp
F:7JY
|
CA |
|
HF Company SA
PAR:ALHF
|
FR |
|
Mitsubishi HC Capital Inc
OTC:MIUFY
|
JP |
|
N
|
NPK Co Ltd
KOSDAQ:048830
|
KR |
|
Gabriel Resources Ltd
XTSX:GBU
|
UK |
|
S
|
Strategic Minerals PLC
F:24S
|
UK |
|
Kingfisher PLC
XETRA:KFI1
|
UK |
|
Dian Swastatika Sentosa Tbk PT
IDX:DSSA
|
ID |
|
T
|
Texchem Resources Bhd
KLSE:TEXCHEM
|
MY |
|
S
|
Stora Enso Oyj
LSE:0CX9
|
FI |
Bankruptcy Probability
Boiron SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Boiron SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Boiron SA
PAR:BOI
|
312.5m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
620.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
382.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
370B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
241.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
201.3B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
289.1B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
170.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Boiron SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Boiron SA has total debt of 20m EUR. This includes both short-term (0 EUR) and long-term (20m EUR) debt.
You can find a full breakdown on its Balance Sheet.